Radius Health Offers Updates On Oncology Programs: Says Phase 3 Elacestrant Study Open For Enrollment, Won Fast Track Designation, Pre-Clinical Data Showed Further Evidence Of Anti-Tumor Activity, RAD140 Phase 1 Study Continues To Enroll Patients
Benzinga Newsdesk